Trial Profile

An open-label, multiple ascending dose escalation, phase 1 study will evaluate KSI-501 in patients with diabetic macular edema. an open-label, multiple ascending dose study

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 08 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 May 2024 According to Kodiak media release,data from this study will be presented at Association for Research in Vision and Ophthalmology 2024 Annual Meeting, being held from May 5-9 in Seattle, Washington.
30 Jan 2024 According to a Kodiak Sciences media release, results of this study will be presented at the Angiogenesis, Exudation, and Degeneration 2024 virtual meeting on Saturday, February 3, 2024, at 3:30 PM ET.
14 Nov 2023 According to a Kodiak Sciences media release, clinical data are expected to be presented in the first quarter of 2024 at an upcoming scientific meeting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com